查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1564990

血块管理设备的全球市场

Clot Management Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 179 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球血栓管理设备市场预计将达到 29 亿美元

2023 年全球血栓管理设备市场估计为 21 亿美元，预计到 2030 年将达到 29 亿美元，2023-2030 年分析期间复合年增长率为 4.6%。经皮血栓切除装置是本报告分析的细分市场之一，预计复合年增长率为 4.8%，到分析期结束时将达到 11 亿美元。在分析期间，导管直接溶栓 (CDT) 设备领域的复合年增长率预计为 4.0%。

美国市场预计将达到5.799亿美元，中国预计复合年增长率为4.4%。

预计 2023 年美国血栓管理设备市场规模将达 5.799 亿美元。中国作为世界第二大经济体，预计2030年市场规模将达到4.634亿美元，2023-2030年分析期间复合年增长率为4.4%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 4.2% 和 3.8%。在欧洲，德国的复合年增长率预计为 4.6%。

全球血栓管理设备市场—主要趋势与驱动因素总结

为什么血块管理设备成为现代医学的重要工具？

由于血栓形成引起的疾病（例如深层静脉栓塞症（DVT）、肺动脉栓塞（PE）和缺血性中风）的盛行率不断增加，血栓管理装置在现代医学中受到了极大的关注。这些疾病造成严重的健康风险，包括危及生命的併发症，如心臟病、中风和慢性静脉功能不全。心血管疾病的增加、人口老化以及肥胖和久坐生活方式等与生活方式相关的危险因素，都导致需要采取干预措施清除和管理血栓的病例迅速增加。用于溶解、移除和预防血栓的血栓管理装置被认为是改善患者预后和降低长期併发症风险的重要工具。随着微创手术的出现，这些设备已成为首选的治疗选择，因为它们比开放性手术和长期抗凝血等传统方法提供更快的恢復、更少的併发症和更有针对性的治疗方法。

科技进步如何改变血块管理解决方案？

由于技术进步使手术过程更安全、更快速、更有效，血块管理设备的前景正在迅速发展。最重要的进步之一是机械血栓切除装置领域，该装置旨在物理去除动脉和静脉中的血块，通常是在微创、基于导管的手术过程中进行。这些设备可以及时清除血块，恢復大脑的血流并防止永久性损伤，彻底改变了缺血性中风的治疗方法。此外，直接导管溶栓（将溶栓剂直接施用到凝块部位）已显示出准确性和安全性的提高。抽吸导管（利用吸力去除血块）和旋转血栓切除系统（将血块分解成更小的碎片以便于处理）等设备在临床上越来越多地用于治疗 DVT 和 PE。此外，生物可吸收血栓移除装置和血栓摘取支架的开发提供了侵入性较小、长期併发症较少的选择。这些进步不仅提高了血栓管理设备的有效性，而且还为治疗复杂的高风险患者开闢了新途径，并将这些技术扩展到更广泛的医疗环境中的使用。

血栓管理设备在哪些方面影响最大？

事实证明，血栓管理设备在多个医疗领域可以挽救生命，特别是在循环系统、神经科和急诊医学领域。在循环系统中，血栓管理装置的使用对于治疗急性冠状动脉症候群和静脉血栓栓塞症(VTE) 至关重要。这些设备可以快速恢復血液流动，并有助于防止血栓形成，血栓形成可能导致心臟病和其他严重併发症。在神经病学中，机械血栓切除装置被认为是治疗大血管闭塞引起的缺血性中风的黄金标准。在关键时间内快速清除血栓可以显着改善神经系统结果并降低长期残疾的风险。在急诊医学中，血栓管理设备用于快速解决危及生命的栓塞和静脉闭塞，加快患者康復速度并减轻加护治疗资源的整体负担。此外，癌症患者、长时间不动的患者以及有遗传倾向的患者中血栓相关疾病的盛行率不断增加，导致这些设备在更广泛的医疗机构（从加护病房）中使用门诊诊所的需求正在增长。随着医疗保健相关人员不断完善血栓管理通讯协定，这些设备对提高血栓性疾病患者的生存率和生活品质有重大影响。

促进血栓管理设备市场扩张的因素有哪些？

血栓管理设备市场的成长是由心血管疾病、中风和静脉血栓栓塞症发病率上升等多种因素所推动的。世界人口老化是一个主要因素，老年人由于血液循环减少、合併症和长时间不动而面临更高的血栓风险。此外，肥胖、久坐的生活方式和吸烟等生活习惯进一步加剧了需要血栓管理干预措施的疾病的盛行率。该市场也受到技术进步的推动，这些技术进步使血栓切除术更安全、更快速、更容易获得。机械取栓设备（例如血栓摘取支架和抽吸系统）的创新极大地改善了患者的治疗效果，特别是在中风治疗方面。微创手术的日益普及，与传统手术相比，恢復时间更短，併发症更少，也是市场扩张的关键驱动力。此外，随着医疗保健提供者专注于缩短住院时间和改善长期结果，对能够快速有效去除血栓的设备的需求不断增加。有利的报销政策，尤其是在新兴市场，以及医生和患者对及时血栓干预重要性的认识不断提高，进一步推动了市场的发展。随着血栓相关疾病的发病率持续上升，由于这些不同的因素，对先进血栓管理设备的需求预计将显着增长。

受访企业范例（11家知名企业）

  • Boston Scientific Corporation
  • Cook Medical LLC
  • DePuy Synthes
  • Edwards Lifesciences Corporation
  • iVascular SLU
  • LeMaitre Vascular, Inc.
  • Medtronic PLC
  • Straub Medical AG
  • Teleflex Inc.
  • Vascular Solutions, Inc.

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他领域

第四章 比赛

简介目录
Product Code: MCP11053

Global Clot Management Devices Market to Reach US$2.9 Billion by 2030

The global market for Clot Management Devices estimated at US$2.1 Billion in the year 2023, is expected to reach US$2.9 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2023-2030. Percutaneous Thrombectomy Devices, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$1.1 Billion by the end of the analysis period. Growth in the Catheter-Directed Thrombolysis (CDT) Devices segment is estimated at 4.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$579.9 Million While China is Forecast to Grow at 4.4% CAGR

The Clot Management Devices market in the U.S. is estimated at US$579.9 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$463.4 Million by the year 2030 trailing a CAGR of 4.4% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.2% and 3.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Global Clot Management Devices Market - Key Trends and Drivers Summarized

Why Are Clot Management Devices Becoming a Critical Tool in Modern Medicine?

Clot management devices have gained significant attention in modern medicine due to the increasing prevalence of conditions like deep vein thrombosis (DVT), pulmonary embolism (PE), and ischemic strokes, which are all caused by the formation of blood clots. These conditions pose serious health risks, including life-threatening complications like heart attacks, strokes, and chronic venous insufficiency. The growing incidence of cardiovascular diseases, an aging population, and lifestyle-related risk factors such as obesity and sedentary behavior have all contributed to a surge in cases requiring intervention for blood clot removal or management. Clot management devices, designed to either dissolve, remove, or prevent blood clots, are seen as critical tools in improving patient outcomes and reducing the risk of long-term complications. With the advent of minimally invasive procedures, these devices have become a preferred treatment option over traditional methods like open surgery or long-term anticoagulant therapy, as they offer quicker recovery times, fewer complications, and more targeted treatment approaches.

How Are Technological Advancements Transforming Clot Management Solutions?

The clot management device landscape has evolved rapidly thanks to technological advancements that are making procedures safer, faster, and more effective. One of the most significant developments is in the area of mechanical thrombectomy devices, which are designed to physically remove clots from arteries or veins, typically during minimally invasive catheter-based procedures. These devices have revolutionized the treatment of ischemic strokes by allowing for timely removal of clots, thereby restoring blood flow to the brain and preventing permanent damage. Additionally, catheter-directed thrombolysis, where clot-dissolving agents are delivered directly to the site of the clot, has seen improvements in both precision and safety. Devices such as aspiration catheters, which use suction to remove clots, and rotational thrombectomy systems, which break clots into smaller, more manageable pieces, are increasingly being utilized in clinical practice to treat DVT and PE. Furthermore, the development of bioabsorbable clot retrieval devices and stent retrievers provides a less invasive option with fewer long-term complications. These advancements are not only improving the efficacy of clot management devices but are also opening new avenues for the treatment of complex and high-risk patients, expanding the use of these technologies in broader medical settings.

Where Are Clot Management Devices Making the Greatest Impact?

Clot management devices have proven to be life-saving in a variety of medical fields, particularly in cardiology, neurology, and emergency medicine. In cardiology, the use of clot management devices is critical in treating acute coronary syndromes and venous thromboembolism (VTE), which includes both DVT and PE. These devices help to quickly restore blood flow and prevent the progression of clots that can lead to heart attacks or other serious complications. In neurology, mechanical thrombectomy devices are now considered the gold standard for treating ischemic strokes caused by large vessel occlusions. Rapid clot removal within the crucial time window can significantly improve neurological outcomes and reduce the risk of long-term disability. In emergency medicine, clot management devices are used to quickly address life-threatening embolisms or venous blockages, allowing patients to recover more rapidly and reducing the overall strain on intensive care resources. The rising prevalence of clot-related conditions in patients with cancer, long-term immobility, or genetic predispositions has also increased the need for these devices across a broader range of healthcare settings, from intensive care units to outpatient clinics. As medical professionals continue to refine clot management protocols, these devices are making a profound impact on improving survival rates and quality of life for patients with thrombotic diseases.

What Factors are Driving the Expansion of the Clot Management Devices Market?

The growth in the clot management devices market is driven by several factors, including the rising incidence of cardiovascular diseases, strokes, and venous thromboembolism. An aging global population is a key contributor, as older individuals are at higher risk for blood clots due to slower circulation, comorbid conditions, and prolonged immobility. Additionally, lifestyle factors such as increasing rates of obesity, sedentary lifestyles, and smoking are further exacerbating the prevalence of conditions that require clot management intervention. The market is also propelled by technological advancements that have made clot removal procedures safer, quicker, and more accessible. Innovations in mechanical thrombectomy devices, such as stent retrievers and aspiration systems, have drastically improved patient outcomes, particularly in stroke management. The growing adoption of minimally invasive procedures, which offer reduced recovery times and fewer complications compared to traditional surgery, is another major driver of market expansion. Moreover, as healthcare providers focus on reducing hospital stays and improving long-term outcomes, there is increased demand for devices that can provide fast, effective clot resolution. Favorable reimbursement policies, particularly in developed healthcare markets, alongside rising awareness among physicians and patients about the importance of timely clot intervention, are further fueling the market. As the incidence of clot-related conditions continues to rise, the demand for advanced clot management devices is expected to grow significantly, driven by these diverse factors.

Select Competitors (Total 11 Featured) -

  • Boston Scientific Corporation
  • Cook Medical LLC
  • DePuy Synthes
  • Edwards Lifesciences Corporation
  • iVascular S.L.U
  • LeMaitre Vascular, Inc.
  • Medtronic PLC
  • Straub Medical AG
  • Teleflex Inc.
  • Vascular Solutions, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Global Economic Update
    • Clot Management Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cardiovascular Diseases Propels Demand for Clot Management Devices
    • Increasing Incidence of Venous Thromboembolism (VTE) and Pulmonary Embolism (PE) Drives Market Growth
    • Advancements in Mechanical Thrombectomy Devices Strengthen the Business Case for Clot Removal Technologies
    • Expanding Use of Catheter-Directed Thrombolysis (CDT) Broadens the Addressable Market for Clot Management Solutions
    • Rising Adoption of Minimally Invasive Procedures Fuels Demand for Clot Management Devices
    • Increasing Focus on Stroke Prevention Throws the Spotlight on Effective Thrombectomy Devices
    • Growing Use of Clot Retrieval Devices in Emergency Rooms Accelerates Market Expansion
    • Development of Bioabsorbable Stents and Devices Expands Market Potential for Safer Clot Management
    • Rising Aging Population and Sedentary Lifestyles Sustain Demand for Clot Management Solutions
    • Increased Awareness of Stroke and Heart Attack Prevention Propels Market Growth for Prophylactic Clot Management Devices
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Clot Management Devices Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Clot Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Clot Management Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Clot Management Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Percutaneous Thrombectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Percutaneous Thrombectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Percutaneous Thrombectomy Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Catheter-Directed Thrombolysis (CDT) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Catheter-Directed Thrombolysis (CDT) Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Catheter-Directed Thrombolysis (CDT) Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Inferior Vena Cava Filters (IVCF) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Inferior Vena Cava Filters (IVCF) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Inferior Vena Cava Filters (IVCF) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Neurovascular Embolectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Neurovascular Embolectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Neurovascular Embolectomy Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Embolectomy Balloon Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Embolectomy Balloon Catheters by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Embolectomy Balloon Catheters by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: World 16-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Clot Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2024 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2024 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • JAPAN
    • Clot Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2024 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • CHINA
    • Clot Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2024 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: China 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • EUROPE
    • Clot Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Clot Management Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Clot Management Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Clot Management Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2024 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • FRANCE
    • Clot Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2024 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: France 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • GERMANY
    • Clot Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2024 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2024 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Clot Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2024 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Rest of Europe 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2024 & 2030
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Rest of Europe Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Rest of Europe 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Clot Management Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Asia-Pacific 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2024 & 2030
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Asia-Pacific 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030
  • REST OF WORLD
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Clot Management Devices by Segment - Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of World 16-Year Perspective for Clot Management Devices by Segment - Percentage Breakdown of Value Sales for Percutaneous Thrombectomy Devices, Catheter-Directed Thrombolysis (CDT) Devices, Inferior Vena Cava Filters (IVCF), Neurovascular Embolectomy Devices and Embolectomy Balloon Catheters for the Years 2014, 2024 & 2030
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 99: Rest of World Historic Review for Clot Management Devices by End-Use - Hospitals and Diagnostic Centers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Rest of World 16-Year Perspective for Clot Management Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals and Diagnostic Centers for the Years 2014, 2024 & 2030

IV. COMPETITION